A. A. Yakovlev

527 total citations
37 papers, 388 citations indexed

About

A. A. Yakovlev is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, A. A. Yakovlev has authored 37 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Infectious Diseases and 8 papers in Hepatology. Recurrent topics in A. A. Yakovlev's work include HIV/AIDS Research and Interventions (14 papers), HIV, Drug Use, Sexual Risk (11 papers) and Hepatitis C virus research (8 papers). A. A. Yakovlev is often cited by papers focused on HIV/AIDS Research and Interventions (14 papers), HIV, Drug Use, Sexual Risk (11 papers) and Hepatitis C virus research (8 papers). A. A. Yakovlev collaborates with scholars based in Russia, United States and Germany. A. A. Yakovlev's co-authors include Jeffrey A. Kelly, Yuri A. Amirkhanian, Aza Rakhmanova, А. В. Кузнецова, Yuliya Y. Sokolova, Sergei Skarlato, Elizabeth S. Didier, Lisa C. Bowers, Alex R. Rinehart and Monika Peeters and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

A. A. Yakovlev

31 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Yakovlev Russia 12 258 202 103 57 53 37 388
Anne Brink Philippines 6 195 0.8× 168 0.8× 32 0.3× 47 0.8× 28 0.5× 8 265
Peter Miele United States 8 261 1.0× 191 0.9× 85 0.8× 57 1.0× 33 0.6× 10 388
F Alberici Italy 10 487 1.9× 161 0.8× 275 2.7× 60 1.1× 23 0.4× 16 544
Mehrnaz Rasoolinejad Iran 10 170 0.7× 180 0.9× 52 0.5× 31 0.5× 20 0.4× 24 388
Debi Boeras United States 5 124 0.5× 130 0.6× 56 0.5× 47 0.8× 24 0.5× 8 264
Thérèse N’Dri-Yoman Ivory Coast 11 507 2.0× 424 2.1× 179 1.7× 22 0.4× 28 0.5× 27 675
Marie-Christine Defer Burkina Faso 7 172 0.7× 325 1.6× 146 1.4× 11 0.2× 57 1.1× 10 444
Zhengwei Ding China 13 335 1.3× 323 1.6× 93 0.9× 12 0.2× 96 1.8× 31 462
Supachai Saisorn Thailand 7 219 0.8× 165 0.8× 72 0.7× 29 0.5× 98 1.8× 7 361
Jean‐Baptiste Andonaba Burkina Faso 5 160 0.6× 274 1.4× 125 1.2× 10 0.2× 37 0.7× 9 373

Countries citing papers authored by A. A. Yakovlev

Since Specialization
Citations

This map shows the geographic impact of A. A. Yakovlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Yakovlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Yakovlev more than expected).

Fields of papers citing papers by A. A. Yakovlev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Yakovlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Yakovlev. The network helps show where A. A. Yakovlev may publish in the future.

Co-authorship network of co-authors of A. A. Yakovlev

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Yakovlev. A scholar is included among the top collaborators of A. A. Yakovlev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Yakovlev. A. A. Yakovlev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakovlev, A. A., et al.. (2022). Virological failures of primary interferon-free therapy in patients with chronic HCV RNA viremia and successful repeated interferon-free therapy. HIV Infection and Immunosuppressive Disorders. 14(3). 100–109.
2.
Yakovlev, A. A., et al.. (2020). Specific Features of Economic Cooperation of Russia and China with Central and Eastern European Countries. Economics and Management. 26(5). 464–478. 1 indexed citations
3.
Yakovlev, A. A., et al.. (2019). MAIN REASONS AND CURRENT METHODS OF CORRECTION OF POOR ADHERENCE TO ANTIRETROVIRAL TREATMENT IN DIFFICULT PATIENTS. HIV Infection and Immunosuppressive Disorders. 10(4). 37–56. 5 indexed citations
4.
Yakovlev, A. A., et al.. (2018). Technology of computer stabilography with biofeedback in the rehabilitation of patients with paraproteinemic polyneuropathy. Research Repository Saint Petersburg State University (Saint Petersburg State University). 13(2). 174–184. 1 indexed citations
5.
Yakovlev, A. A., et al.. (2018). RISK FACTORS THAT CONTRIBUTE TO THE FORMATION OF COMBINED FORMS OF TUBERCULOSIS AND HIV INFECTION IN PRIMORSKY KRAI. Pacific Medical Journal. 3. 87–91. 3 indexed citations
6.
Yakovlev, A. A., et al.. (2017). LETHAL OUTCOMES IN INFLUENZA: CLINIC-PATHOLOGICAL APPROACH TO IMMEDIATE DEATH CAUSES. Journal Infectology. 9(4). 53–58. 1 indexed citations
7.
8.
Amirkhanian, Yuri A., Jeffrey A. Kelly, Wayne DiFranceisco, et al.. (2016). Predictors of HIV Care Engagement, Antiretroviral Medication Adherence, and Viral Suppression Among People Living with HIV Infection in St. Petersburg, Russia. AIDS and Behavior. 22(3). 791–799. 35 indexed citations
9.
Кузнецова, А. В., et al.. (2016). Barriers and Facilitators of HIV Care Engagement: Results of a Qualitative Study in St. Petersburg, Russia. AIDS and Behavior. 20(10). 2433–2443. 41 indexed citations
10.
11.
Nelson, David R., K. Rajender Reddy, Adrian M. Di Bisceglie, et al.. (2014). ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients with History of Depression or Bipolar Disorder: Pooled Analysis of Efficacy and Safety in Phase 3 Trials. Hepatology. 60. 5 indexed citations
12.
Yakovlev, A. A., et al.. (2014). ВАРИЦЕЛЛА ЗОСТЕРНАЯ ИНФЕКЦИЯ У ВЗРОСЛЫХ ВИЧ-ИНФИЦИРОВАННЫХ ПАЦИЕНТОВ. HIV Infection and Immunosuppressive Disorders. 6(3). 39–45. 1 indexed citations
13.
Amirkhanian, Yuri A., et al.. (2014). Using social network methods to reach out‐of‐care or ART‐nonadherent HIV+ injection drug users in Russia: addressing a gap in the treatment cascade. Journal of the International AIDS Society. 17(4S3). 19594–19594. 3 indexed citations
14.
Kelly, Jeffrey A., et al.. (2014). Stigma reduces and social support increases engagement in medical care among persons with HIV infection in St. Petersburg, Russia. Journal of the International AIDS Society. 17(4S3). 19618–19618. 22 indexed citations
15.
Kissin, Dmitry M., Aza Rakhmanova, Elena Vinogradova, et al.. (2008). Rapid HIV testing and prevention of perinatal HIV transmission in high-risk maternity hospitals in St. Petersburg, Russia. American Journal of Obstetrics and Gynecology. 198(2). 183.e1–183.e7. 21 indexed citations
16.
Никитин, И. Г., A. A. Yakovlev, Pavel Bogomolov, et al.. (2007). [11] PHASE 2 STUDY OF OMEGA INTERFERON ALONE OR IN COMBINATION WITH RIBAVIRIN IN SUBJECTS WITH CHRONIC HEPATITIS C GENOTYPE-1 INFECTION. Journal of Hepatology. 46. S8–S8. 16 indexed citations
17.
Vinogradova, Elena, et al.. (2003). HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002. The Lancet. 362(9400). 1981–1982. 14 indexed citations
18.
Rakhmanova, Aza, A. A. Yakovlev, Monika Peeters, et al.. (2003). A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects. AIDS. 17(17). 2487–2494. 68 indexed citations
19.
Yakovlev, A. A., et al.. (1985). Isomerizates as components of unleaded gasoline. Chemistry and Technology of Fuels and Oils. 21(5). 227–230. 1 indexed citations
20.
Yakovlev, A. A., et al.. (1985). Blends of isomerizates with methyl tert-butyl ether as components of unleaded automotive gasoline. Chemistry and Technology of Fuels and Oils. 21(11). 553–556. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Brink Breakdown of academic impact, for papers by Peter Miele Breakdown of academic impact, for papers by F Alberici Breakdown of academic impact, for papers by Mehrnaz Rasoolinejad Breakdown of academic impact, for papers by Debi Boeras Breakdown of academic impact, for papers by Thérèse N’Dri-Yoman Breakdown of academic impact, for papers by Marie-Christine Defer Breakdown of academic impact, for papers by Zhengwei Ding Breakdown of academic impact, for papers by Supachai Saisorn Breakdown of academic impact, for papers by Jean‐Baptiste Andonaba
Rankless by CCL
2026